For the Inventor, By the Inventor

Enter assignee name

Bnei Brak, Israel

Chemagis Ltd.

USPTO Granted Patents = 37

% Expired Patents = 81.1

EPO Patents = 4

Forward Citations = 78

Loading Chart...

Loading Chart...

68 inventors (with patents filed for the assignee):

Joseph Kaspi (24 out of 29 patents)

Oded Arad (18 out of 19 patents)

Vladimir Naddaka (9 out of 10 patents)

4. Shady Saeed (7 out of 7 patents)

5. Ori Lerman (7 out of 8 patents)

6. Michael Brand (5 out of 5 patents)

7. Eyal Klopfer (4 out of 4 patents)

8. Yana Sery (4 out of 4 patents)

9. Mohammed Alnabari (4 out of 4 patents)

10. Edna Danon (4 out of 4 patents)

11. Lior Zelikovitch (4 out of 4 patents)

12. Oded Friedman (4 out of 4 patents)

13. Stephen Cherkez (3 out of 6 patents)

14. Itai Adin (3 out of 5 patents)

15. Sonia Krivonos (3 out of 5 patents)

Core Competencies:

Atracurium

Imiquimod

Montelukast

Cisatracurium

Purification

Pharmaceutical Compositions

Rotigotine

Letrozole

Donepezil

Midodrine

Temozolomide

Imatinib

37 patents: Sort by Forward Citations

1. 8461338 - (1R, 1'R)-atracurium salts separation process (2013-06-11),

2. 8357807 - Isoquinolinium compounds useful in the preparation of cisatracurium and associated intermediates (2013-01-22),

3. 8357805 - (1R,1'R)-atracurium salts separation process (2013-01-22),

4. 8354537 - [object Object] (2013-01-15),

5. 8344165 - Crystalline rotigotine base and preparation process therefor (2013-01-01),

6. 8334388 - Palonosetron salts and processes for preparation and purification thereof (2012-12-18),

7. 8293912 - Process for producing cisatracurium compounds and associated intermediates (2012-10-23),

8. 7943771 - Imiquimod production process (2011-05-17),

9. 7776852 - Process for producing highly pure midazolam and salts thereof (2010-08-17),

10. 7745471 - Derivatives of 1,2-benzisoxazole-3-methane sulfonic acid as novel intermediates for the synthesis of zonisamide (2010-06-29),

11. 7659398 - Imiquimod production process (2010-02-09),

12. 7615632 - Crystalline forms of temozolomide (2009-11-10),

13. 7612202 - Process for preparing temozolomide (2009-11-03),

14. 7592459 - Use of purified donepezil maleate for preparing pharmaceutically pure amorphous donepezil hydrochloride (2009-09-22),

15. 7579461 - Processes for the preparation of rocuronium bromide and intermediates thereof (2009-08-25),

Chemagis Ltd. is a technology-driven company based in Bnei Brak, Israel, specializing in innovative solutions for the chemical and pharmaceutical industries. The organization focuses on the development and manufacturing of advanced materials and processes that enhance efficiency and sustainability in various applications. With a commitment to research and development, Chemagis aims to address complex challenges in the sector, leveraging cutting-edge technologies to deliver high-quality products and services tailored to the needs of its clients.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

37 Patents

#1 in Bnei Brak

#146 in Israel

#18,238 in the World

Bnei Brak, Israel

Chemagis Ltd.

Forward Citations = 78

68 inventors:

Joseph Kaspi (24 out of 29 patents)

Oded Arad (18 out of 19 patents)

Vladimir Naddaka (9 out of 10 patents)

4. Shady Saeed (7 out of 7 patents)

5. Ori Lerman (7 out of 8 patents)

Please report any incorrect information to [email protected]

Loading…